158 related articles for article (PubMed ID: 26019019)
1. Impact of synthetic ghrelin administration for patients with severe body weight reduction more than 1 year after gastrectomy: a phase II clinical trial.
Takiguchi S; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Miyata H; Hosoda H; Kangawa K; Mori M; Doki Y
Surg Today; 2016 Mar; 46(3):379-85. PubMed ID: 26019019
[TBL] [Abstract][Full Text] [Related]
2. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study.
Adachi S; Takiguchi S; Okada K; Yamamoto K; Yamasaki M; Miyata H; Nakajima K; Fujiwara Y; Hosoda H; Kangawa K; Mori M; Doki Y
Gastroenterology; 2010 Apr; 138(4):1312-20. PubMed ID: 20060830
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of ghrelin synthesis administration for upper GI surgery.
Takiguchi S; Hiura Y; Miyazaki Y; Takata A; Murakami K; Doki Y
Methods Enzymol; 2012; 514():409-31. PubMed ID: 22975068
[TBL] [Abstract][Full Text] [Related]
4. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy.
Takachi K; Doki Y; Ishikawa O; Miyashiro I; Sasaki Y; Ohigashi H; Murata K; Nakajima H; Hosoda H; Kangawa K; Sasakuma F; Imaoka S
J Surg Res; 2006 Jan; 130(1):1-7. PubMed ID: 16182310
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy.
Takiguchi S; Takata A; Murakami K; Miyazaki Y; Yanagimoto Y; Kurokawa Y; Takahashi T; Mori M; Doki Y
Gastric Cancer; 2014 Apr; 17(2):200-5. PubMed ID: 24253567
[TBL] [Abstract][Full Text] [Related]
6. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study.
Hiura Y; Takiguchi S; Yamamoto K; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Miyata H; Fujiwara Y; Mori M; Kangawa K; Doki Y
Cancer; 2012 Oct; 118(19):4785-94. PubMed ID: 22282373
[TBL] [Abstract][Full Text] [Related]
7. Total gastrectomy-induced reductions in food intake and weight are counteracted by rikkunshito by attenuating glucagon-like peptide-1 elevation in rats.
Taguchi M; Dezaki K; Koizumi M; Kurashina K; Hosoya Y; Lefor AK; Sata N; Yada T
Surgery; 2016 May; 159(5):1342-50. PubMed ID: 26775072
[TBL] [Abstract][Full Text] [Related]
8. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.
Karamanakos SN; Vagenas K; Kalfarentzos F; Alexandrides TK
Ann Surg; 2008 Mar; 247(3):401-7. PubMed ID: 18376181
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite.
Akamizu T; Iwakura H; Ariyasu H; Hosoda H; Murayama T; Yokode M; Teramukai S; Seno H; Chiba T; Noma S; Nakai Y; Fukunaga M; Nakai Y; Kangawa K;
Eur J Endocrinol; 2008 Apr; 158(4):491-8. PubMed ID: 18362296
[TBL] [Abstract][Full Text] [Related]
10. Long-term changes in gut hormones, appetite and food intake 1 year after subtotal gastrectomy with normal body weight.
Jeon TY; Lee S; Kim HH; Kim YJ; Lee JG; Jeong DW; Kim YJ
Eur J Clin Nutr; 2010 Aug; 64(8):826-31. PubMed ID: 20485300
[TBL] [Abstract][Full Text] [Related]
11. Z-505, an Oral Ghrelin Receptor Agonist, Attenuates Anorexia After Total Gastrectomy in Rats.
Shiomi Y; Yoshimura M; Hori Y; Ohira Y; Nagahama K; Ozaki T; Takei M; Tanaka T; Uno T
J Surg Res; 2020 Feb; 246():527-534. PubMed ID: 31668932
[TBL] [Abstract][Full Text] [Related]
12. Serum ghrelin levels partially recover with the recovery of appetite and food intake after total gastrectomy.
Koizumi M; Hosoya Y; Dezaki K; Yada T; Hosoda H; Kangawa K; Nagai H; Lefor AT; Sata N; Yasuda Y
Surg Today; 2014 Nov; 44(11):2131-7. PubMed ID: 24604119
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction.
Yamamoto K; Takiguchi S; Miyata H; Adachi S; Hiura Y; Yamasaki M; Nakajima K; Fujiwara Y; Mori M; Kangawa K; Doki Y
Surgery; 2010 Jul; 148(1):31-8. PubMed ID: 20096432
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Jin DK; Kim S
J Surg Res; 2007 Dec; 143(2):344-9. PubMed ID: 17688884
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice.
Dornonville de la Cour C; Lindqvist A; Egecioglu E; Tung YC; Surve V; Ohlsson C; Jansson JO; Erlanson-Albertsson C; Dickson SL; Håkanson R
Gut; 2005 Jul; 54(7):907-13. PubMed ID: 15849166
[TBL] [Abstract][Full Text] [Related]
16. Effects of rikkunshito, a kampo medicine, on quality of life after proximal gastrectomy.
Gunji S; Ueda S; Yoshida M; Kanai M; Terajima H; Takabayashi A
J Surg Res; 2013 Dec; 185(2):575-80. PubMed ID: 23856127
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin and PYY(3-36) in gastrectomized and vagotomized patients: relations with appetite, energy intake and resting energy expenditure.
Kamiji MM; Troncon LE; Antunes-Rodrigues J; Elias LL; de Castro M; Oliveira RB
Eur J Clin Nutr; 2010 Aug; 64(8):845-52. PubMed ID: 20485299
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy.
le Roux CW; Neary NM; Halsey TJ; Small CJ; Martinez-Isla AM; Ghatei MA; Theodorou NA; Bloom SR
J Clin Endocrinol Metab; 2005 Aug; 90(8):4521-4. PubMed ID: 15914532
[TBL] [Abstract][Full Text] [Related]
19. Changes in ghrelin concentrations one year after resective and non-resective gastric bypass: associations with weight loss and energy and macronutrient intakes.
Carrasco F; Rojas P; Csendes A; Codoceo J; Inostroza J; Basfi-fer K; Papapietro K; Watkins G; Rojas J; Ruz M
Nutrition; 2012 Jul; 28(7-8):757-61. PubMed ID: 22305536
[TBL] [Abstract][Full Text] [Related]
20. Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome.
De Waele K; Ishkanian SL; Bogarin R; Miranda CA; Ghatei MA; Bloom SR; Pacaud D; Chanoine JP
Eur J Endocrinol; 2008 Oct; 159(4):381-8. PubMed ID: 18603572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
